Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis
Clinical trial NCT05953545 · WITHDRAWN
Trial details
- NCT number
- NCT05953545
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-22
- Primary completion
- 2024-05-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.